PharmaDeals Reports
The Royalty Rate Report is the definitive guide for the industry and provides in-depth analysis of one of the most important but elusive components of a biopharma deal – the royalty rate.
The Royalty Rate Report: A comprehensive assessment of valuation in the
pharmaceutical sector
Key Benefits
- First hand insight on royalty rates from deal-makers via our PharmaDeals survey
- Gain opinions and advice from leading industry deal-makers who share their thoughts on royalty rates
- Receive guidance on the best methodologies to use including benchmarking and expected net present value when calculating royalty rates for vital decision making
- Understand the differences in perception of value between biotechs and pharmaceutical companies and how that impacts the value of a deal
- Review actual royalty rate data supported by case histories and be better informed before negotiating your next deal
|
Published |
|
| Request more information | |
The report includes:
- A historical overview of royalties, their relevance to the biopharma industry and the psychology of royalty structures
- Introduction to methods for calculating useful financial data missing from the public domain - essential for dealmakers in benchmarking and determining value in a deal and its relationship with future royalty streams
- Thought leadership in determining royalty rates including the concept of effective royalties in the analysis of deal structures; calculating royalty rates in biotechnology deals supported by key opinion leader insight
- A detailed presentation of key methodologies - benchmarking and expected net present value - used in calculating royalty rates
- Market data and current trends in royalty rate disclosure by development phase, by indication and by the top pharmaceutical companies
- Industry perception of royalties including a review of the literature, discussion on tiered royalty rates and critical analysis of the results of the PharmaDeals Royalty Rates Survey
- A comprehensive appendix includes a listing of all royalty reporting deals from the last 10 years.
Delivery:
- One year subscription to the report published on the interactive online IMS Syndicated Analytics Library
- IMS Syndicated Analytics Library offers full searchability including cut and create your own report
- Export tables, figures and whole chapters into Excel, PowerPoint and Word
- Nine language automatic translation – choose to view report in French, German, Chinese, Italian, Spanish, Japanese, Portuguese, Korean or Russian
Contact us today
pdenquiries@uk.imshealth.com
pdenquiries@uk.imshealth.com
Login Problems
